TASOGARE
2021-12-22

I've seen something similar happen with another stock - TBIO...it was kept down for months and Sanofi swooped in a bought it. Stock had a potential of $100 a share on the second phase of a clinical trial - we ended up getting low-balled by the Boards - and ended up with a quarter of what the potential was. Even though any company can replicate the SoFi model - they would need time to increase membership.$Translate Bio Inc.(TBIO)$ $SoFi Technologies Inc.(SOFI)$

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法
2